Merck Annual Report 2012 - Sitemap (optimized for printing)

To our Shareholders
- Letter from
  Karl-Ludwig Kley
- Executive Board
- Business Development 2008-2012
- Financial Calendar
- Merck in the Capital Market
  - Share data
  - Shareholder
Group Management Report
- Merck at a glance
  - Our divisions
    - Merck Serono
    - Consumer Health
    - Performance Materials
    - Merck Millipore
  - Company strategy
- Corporate Responsibility
  - Employees
  - International human resources work
  - Employee diversity
  - Products and environment
  - Society
- Economic Situation
- Financial Position and Results of Operations
  - Business development
  - Expenses
  - Result
  - Quarterly performance 2012
  - Assets and liabilities
  - Free cash flow
  - Key performance indicators
  - Conclusion
- Merck Serono
  - Business development
  - Regions
  - Major products
  - Therapeutic areas
  - Research & Development
    - Overview compounds
    - Strategy by therapeutic areas
    - Clinical pipeline
- Consumer Health
  - Business development
  - Regions
  - Brands
- Performance Materials
  - Business development
  - Regions
  - OLED displays
- Merck Millipore
  - Business development
  - Regions
  - Business units
- Corporate and Other
- Risk Report
  - Business-related risks
  - Financial risks
  - Legal risks
  - Human resources risks
  - Information technology risks
  - Environmental and safety risks
- Report on Expected Developments
  - Global economy
  - Sector
  - Forecast for sales and operating result
  - Merck Serono
  - Consumer Health
  - Performance Materials
  - Merck Millipore
  - Summary
- Capital and shares
- Subsequent Events
Corporate Governance
- Statement on Corporate Governance
  - Merck KGaA
  - Statement of Compliance
  - Compensation report
    - Executive Board
    - Supervisory Board
    - Ownership of shares
- Corporate Governance Practices
  - Principles
  - Values and compliance
- Procedures of the corporate bodies
  - Executive Board
  - Supervisory Board
  - Board of Partners of E. Merck KG
- Report of the Supervisory Board
- Objectives of the Supervisory Board
Financial Statements
- Income Statement
- Comprehensive Income
- Balance Sheet
- Cash Flow Statement
- Changes in Net Equity
Notes
- General
  - Company information
  - Reporting principles
- Scope of consolidation
  - Changes in the scope of consolidation
  - Acquisitions
- Accounting policies
  - Accounting and measurement principles
  - Discretionary decisions and estimation uncertainty
  - Consolidation methods
  - Currency translation
  - Recognition of sales and other revenue
  - Research and development
  - Financial instruments: Principles
  - Financial instruments: Categories and classes of financial instruments
  - Financial instruments: Derivative and hedge accounting
  - Other non-financial assets and liabilities
  - Inventories
  - Intangible assets
  - Property, plant and equipment
  - Leasing
  - Deferred taxes
  - Provisions
  - Provisions for pensions and other post-employment benefits
- Notes to the consolidated income statement
  - Sales
  - Royalty, license and commission income
  - Cost of sales
  - Marketing and selling expenses
  - Royalty, license and commission expenses
  - Administration expenses
  - Other operating expenses and income
  - One-time items
  - Research and development
  - Amortization of intangible assets
  - Investment result
  - Financial result
  - Income tax
  - Non-controlling interest
  - Earnings per share
- Notes to the balance sheet
  - Cash and cash equivalents
  - Current financial assets
  - Trade accounts receivable
  - Inventories
  - Other assets
  - Tax receivables
  - Intangible assets
  - Property, plant and equipment
  - Non-current financial assets
  - Financial liabilities
  - Trade accounts payable
  - Other liabilities
  - Tax liabilities
  - Provisions
  - Provisions for pensions and other post-employment benefits
  - Equity
- Segment reporting
  - Information by division/country and region
  - Segment reporting
- Notes to the consolidated cash flow statement
  - Net cash flows from operating activities
  - Net cash flows from investing activities
  - Net cash flows from financing activities
  - Free cash flow and business free cash flow
- Other disclosures
  - Derivative financial instruments
  - Management of financial risks
  - Other disclosures on financial instruments
  - Capital management
  - Contingent liabilities
  - Other financial obligations
  - Personnel expenses/Headcount
  - Material costs
  - Auditors’ fees
  - Corporate governance
  - Companies opting for exemption under section 264 (3) HGB or section 264b HGB
  - Related-party disclosures
  - Executive Board and Supervisory Board compensation
  - Information on preparation and approval
  - Subsequent events
  - List of shareholdings
- Auditor's Report
The road to tomorrow
- Objective-driven
- Committed
- Performance-oriented
- Efficient